Deadly sleeping sickness set to be eliminated in 6 years

December 22, 2016

Gambian sleeping sickness - a deadly parasitic disease spread by tsetse flies - could be eliminated in six years in key regions in the Democratic Republic of Congo (DRC), according to new research by the University of Warwick.

Kat Rock and Matt Keeling at the School of Life Sciences, with colleagues in DRC and the Liverpool School of Tropical Medicine, have calculated the impact of different intervention strategies on the population dynamics of tsetse flies and humans - establishing which strategies show the most promise to control and eliminate the disease.

They found that a two-pronged approach - integrating active screening and vector control - could substantially speed up the elimination of Gambian sleeping sickness in high burden areas of DRC.

Without changing current strategy, elimination might not happen until the 22nd century.

The researchers, who work as part of the Neglected Tropical Disease Modelling Consortium, used complex mathematical models to compare the efficacy of six key strategies and twelve variations within two areas of Kwilu province (within former Bandundu province), DRC.

Previous work by the same group indicates that high-risk people are often missed from active screening. The new model concludes that improved active screening - making sure that all people are screened equally, regardless of risk factor - may allow elimination as a public health problem between 2023 and 2031.

If vector control strategies - using "tsetse targets" coated with insecticide to attract and kill flies - are added, this elimination goal is likely to be achieved within four years when coupled with any screening approach.

If DRC adopts any of the new strategies with vector control, transmission would probably be broken within six years of launching the new program in these areas - and over 6000 new infections could be averted between 2017 and 2030.

Strategies which rely only on self-reporting of illness and screening of low-risk individuals are unlikely to lead to elimination of sleeping sickness transmission by 2030, and delay elimination until the next century.

Gambian sleeping sickness, or Gambian human African trypanosomiasis, is caused by a parasite called Trypanosoma brucei gambiense, carried by tsetse flies in Central and West Africa. Without treatment, the disease usually results in death.

In recent years, programmes have performed intense active and passive screening to decrease disease incidence. A few areas have also combined these medical interventions with vector control. But some high prevalence regions of DRC have not achieved the reductions in disease seen in other parts of Africa. Other strategies for elimination will also include reinforced passive screening, new diagnostic tools and improved drugs.

In 2012, the World Health Organization set two public health goals for the control of Gambian sleeping sickness, a parasitic disease spread by the tsetse fly. The first is to eliminate the disease as a public health problem and have fewer than 2000 cases by 2020; while the second goal is to achieve zero transmission around the globe by 2030.

Kat Rock comments:

"We found that vector control has great potential to reduce transmission and, even if it is less effective at reducing tsetse numbers as in other regions, the full elimination goal could still be achieved by 2030.

"We recommend that control programmes use a combined medical and vector control strategy to help combat sleeping sickness."
-end-
The research, "Predicting the Impact of Intervention Strategies for Sleeping Sickness in Two High-Endemicity Health Zones of the Democratic Republic of Congo", is published in PLOS Neglected Tropical Diseases.

University of Warwick

Related Disease Articles from Brightsurf:

CLCN6 identified as disease gene for a severe form of lysosomal neurodegenerative disease
A mutation in the CLCN6 gene is associated with a novel, particularly severe neurodegenerative disorder.

Cellular pathway of genetic heart disease similar to neurodegenerative disease
Research on a genetic heart disease has uncovered a new and unexpected mechanism for heart failure.

Mechanism linking gum disease to heart disease, other inflammatory conditions discovered
The link between periodontal (gum) disease and other inflammatory conditions such as heart disease and diabetes has long been established, but the mechanism behind that association has, until now, remained a mystery.

Potential link for Alzheimer's disease and common brain disease that mimics its symptoms
A new study by investigators from Brigham and Women's Hospital uncovered a group of closely related genes that may capture molecular links between Alzheimer's disease and Limbic-predominant Age-related TDP-43 Encephalopathy, or LATE, a recently recognized common brain disorder that can mimic Alzheimer's symptoms.

Antioxidant agent may prevent chronic kidney disease and Parkinson's disease
Researchers from Osaka University developed a novel dietary silicon-based antioxidant agent with renoprotective and neuroprotective effects.

Tools used to study human disease reveal coral disease risk factors
In a study published in Scientific Reports, a team of international researchers led by University of Hawai'i (UH) at Mānoa postdoctoral fellow Jamie Caldwell used a statistical technique typically employed in human epidemiology to determine the ecological risk factors affecting the prevalence of two coral diseases--growth anomalies, abnormalities like coral tumors, and white syndromes, infectious diseases similar to flesh eating bacteria.

Disease-aggravating mutation found in a mouse model of neonatal mitochondrial disease
The new mitochondrial DNA (mtDNA) variant drastically speeds up the disease progression in a mouse model of GRACILE syndrome.

Human longevity largest study of its kind shows early detection of disease & disease risks
Human Longevity, Inc. (HLI) announced the publication of a ground-breaking study in the journal Proceedings of the National Academy of Sciences (PNAS).

30-year study identifies need of disease-modifying therapies for maple syrup urine disease
A new study analyzes 30 years of patient data and details the clinical course of 184 individuals with genetically diverse forms of Maple Syrup Urine Disease (MSUD), which is among the most volatile and dangerous inherited metabolic disorders.

Long-dormant disease becomes most dominant foliar disease in New York onion crops
Until recently, Stemphylium leaf blight has been considered a minor foliar disease as it has not done much damage in New York since the early 1990s.

Read More: Disease News and Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.